Media Mosiac Gov Solutions Book a Strategy Call
Gov.MediaMosiac β€Ί GovCon News
πŸ› GovCon Intel Opportunities Presolicitations Contract Awards Award Notices Grants Events Regulatory Search πŸ“ Insights
← Back to Regulatory Updates

Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information; Aminobenzoic Acid (PABA) and Trolamine Salicylate

Notice
Health and Human Services Department, Food and Drug Administration
Notice
September 11, 2026
2026-18551

πŸ“„ Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability on its website of the final administrative order (final order) (OTC000008-1) titled "Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information; Aminobenzoic Acid (PABA) and Trolamine Salicylate." This final order amends "Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use" (Over- the-Counter (OTC) Monograph M020) to remove PABA and trolamine salicylate as sunscreen active ingredients. A sunscreen drug product containing PABA or trolamine salicylate is not generally recognized as safe and effective (GRASE).
🎯 Get GovCon Intel Free β†’